000 | 01691 a2200493 4500 | ||
---|---|---|---|
005 | 20250515035846.0 | ||
264 | 0 | _c20070612 | |
008 | 200706s 0 0 eng d | ||
022 | _a1462-8902 | ||
024 | 7 |
_a10.1111/j.1463-1326.2005.00538.x _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aJacob, A N | |
245 | 0 | 0 |
_aThe visceral and subcutaneous fat changes in type 1 diabetes: a pilot study. _h[electronic resource] |
260 |
_bDiabetes, obesity & metabolism _cSep 2006 |
||
300 |
_a524-30 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAdiponectin _xblood |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aBody Composition |
650 | 0 | 4 |
_aCholesterol, HDL _xblood |
650 | 0 | 4 |
_aDiabetes Mellitus, Type 1 _xblood |
650 | 0 | 4 | _aEating |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aGhrelin |
650 | 0 | 4 | _aGlycated Hemoglobin |
650 | 0 | 4 |
_aHemoglobins _xmetabolism |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHypoglycemic Agents _xtherapeutic use |
650 | 0 | 4 |
_aInsulin _xtherapeutic use |
650 | 0 | 4 |
_aIntra-Abdominal Fat _xpathology |
650 | 0 | 4 |
_aLeptin _xblood |
650 | 0 | 4 | _aMagnetic Resonance Imaging |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aPeptide Hormones _xblood |
650 | 0 | 4 | _aPhysical Exertion |
650 | 0 | 4 | _aPilot Projects |
650 | 0 | 4 | _aProspective Studies |
650 | 0 | 4 |
_aSubcutaneous Fat _xpathology |
650 | 0 | 4 |
_aWeight Gain _xdrug effects |
700 | 1 | _aAdams-Huet, B | |
700 | 1 | _aRaskin, P | |
773 | 0 |
_tDiabetes, obesity & metabolism _gvol. 8 _gno. 5 _gp. 524-30 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1463-1326.2005.00538.x _zAvailable from publisher's website |
999 |
_c16505164 _d16505164 |